ArticleScientific reports2017

The Src family kinase inhibitor dasatinib delays pain-related behaviour and conserves bone in a rat model of cancer-induced bone pain.

Camilla Kristine Appel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.